5 nov 2019
CPhI Worldwide 2019
Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals

Exhibitor at CPhI Worldwide 2019 stand 90G20, Finished Dosage Formulations

About us

Wanbang Biopharmaceuticals Co Ltd focuses on developing, manufacturing, and selling pharmaceuticals for patients of diabetes and related cardiovascular diseases. Its products include animal insulin, Glimepiride tablets, Meglumine Adenosine Cyclophosphate, EPO, Bangtan (Telmisatan), and Heparin sodium. The company's products also comprise aloe compound capsules for clearing liver-heat, relaxing bowels, and calming heart for tranquillization; and products in the fields of chemicals, pharmaceuticals, and biotech, such as Human Interferon, Human Erythropoietin, Streptokinase, and Pemetrexed disodium. It sells products through a network of distributors and sales representatives in China and internationally. The company was founded in 1981 and is based in Xuzhou, China. Wanbang Biopharmaceuticals Co Ltd operates as a subsidiary of Shanghai FOSUN Pharmaceutical (Group) Co Ltd.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Capsules More

Products featured at CPhI Worldwide 2019

Categories affiliated with Wanbang Biopharmaceuticals

Wanbang Biopharmaceuticals

Event information

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 90G20